18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: A prospective multicentre evaluation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 9, 2010, Pages 1669-1678

  Ansquer, Catherine ^a,b   Scigliano, Sonia ^c   Mirallié, Eric ^a   Taïeb, David ^d   Brunaud, Laurent ^c   Sebag, Fredéric ^d   Leux, Christophe ^e   Drui, Delphine ^f   Dupas, Benoît ^a   Renaudin, Karine ^a   Kraeber Bodéré, Françoise ^a,b,g  

^a HÔTEL DIEU   (France)

^b Team 12   (France)

^c CHU NANCY BRABOIS   (France)

^d TIMONE HOSPITAL   (France)

^e CHU DE NANTES   (France)

^f CHU de Nantes   (France)

^g CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Adenoma; Adrenal glands; Adrenocortical carcinoma; FDG PET CT; Phaeochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; FLUCIS; FLUORODEOXYGLUCOSE F 18; IODOCHOLESTEROL I 131; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADRENAL CANCER; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GOLD STANDARD; HUMAN; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MULTICENTER STUDY; PROSPECTIVE STUDY; TREATMENT PLANNING; ADRENAL TUMOR; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RECURRENT DISEASE; SCINTISCANNING;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77956190333     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1471-8     Document Type: Article

References (31)

1. J Bertherat H Mosnier-Pudar X Bertagna 2002 Adrenal incidentalomas Curr Opin Oncol 14 58 63 10.1097/00001622-200201000-00011 11790982
2. MM Grumbach BM Biller GD Braunstein KK Campbell JA Carney PA Godley, et al. 2003 Management of the clinically inapparent adrenal mass ("incidentaloma") Ann Intern Med 138 424 429 12614096
3. R Libè C Dall'Asta L Barbetta A Baccarelli P Beck-Peccoz B Ambrosi 2002 Long-term follow-up study of patients with adrenal incidentalomas Eur J Endocrinol 147 489 494 10.1530/eje.0.1470489 12370111
4. GW Boland MA Goldberg MJ Lee WW Mayo-Smith J Dixon MM McNicholas, et al. 1995 Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 194 131 134 1:STN:280: DyaK2M%2FptVSqtQ%3D%3D 7997539
5. JJ Erasmus EF Patz Jr HP McAdams JG Murray J Herndon RE Coleman, et al. 1997 Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography AJR Am J Roentgenol 168 1357 1360 1:STN:280:DyaK2s3nsFKktg%3D%3D 9129444
6. M Yun W Kim N Alnafisi L Lacorte S Jang A Alavi 2001 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI J Nucl Med 42 1795 1799 1:STN:280:DC%2BD38%2FgtlOhuw%3D%3D 11752075
7. A Frilling K Tecklenborg F Weber H Kühl S Müller G Stamatis, et al. 2004 Importance of adrenal incidentaloma in patients with a history of malignancy Surgery 136 1289 1296 10.1016/j.surg.2004.06.060 15657589
8. S Jana T Zhang DM Milstein CR Isasi MD Blaufox 2006 FDG-PET and CT characterization of adrenal lesions in cancer patients Eur J Nucl Med Mol Imaging 33 29 35 10.1007/s00259-005-1915-8 16193311
9. U Metser E Miller H Lerman G Lievshitz S Avital E Even-Sapir 2006 18F-FDG PET/CT in the evaluation of adrenal masses J Nucl Med 47 32 37 16391184
10. MA Blake JM Slattery MK Kalra EF Halpern AJ Fischman PR Mueller, et al. 2006 Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience Radiology 238 970 977 10.1148/radiol.2383042164 16505394
11. YM Sung KS Lee BT Kim JY Choi MJ Chung YM Shim, et al. 2008 (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients Korean J Radiol 9 19 28 10.3348/kjr.2008.9.1.19 18253072
12. GW Boland MA Blake NS Holalkere PF Hahn 2009 PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients AJR Am J Roentgenol 192 956 962 10.2214/AJR.08.1431 19304700
13. R Vikram HD Yeung HA Macapinlac RB Iyer 2008 Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer AJR Am J Roentgenol 191 1545 1551 10.2214/AJR.07.3447 18941099
14. BL Shulkin NW Thompson B Shapiro IR Francis JC Sisson 1999 Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET Radiology 212 35 41 1:STN:280:DyaK1MzjsVWruw%3D%3D 10405717
15. SJ Han TS Kim SW Jeon SJ Jeong M Yun Y Rhee, et al. 2007 Analysis of adrenal masses by 18F-FDG positron emission tomography scanning Int J Clin Pract 61 802 809 10.1111/j.1742-1241.2006.01220.x 17343665
16. D Taïeb F Sebag A Barlier L Tessonnier FF Palazzo I Morange, et al. 2009 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med 50 711 717 10.2967/jnumed.108.060731 19372492
17. L Groussin G Bonardel S Silvéra F Tissier J Coste G Abiven, et al. 2009 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients J Clin Endocrinol Metab 94 1713 1722 10.1210/jc.2008-2302 1:CAS:528: DC%2BD1MXlvVCqtbw%3D 19190108
18. A Shimizu N Oriuchi Y Tsushima T Higuchi J Aoki K Endo 2003 High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome Ann Nucl Med 17 403 406 10.1007/BF03006609 12971640
19. S Maurea M Klain C Mainolfi M Ziviello M Salvatore 2001 The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses J Nucl Med 42 884 892 1:STN:280:DC%2BD3MzitVWqtQ%3D%3D 11390552
20. G Zettinig M Mitterhauser W Wadsak A Becherer C Pirich H Vierhapper, et al. 2004 Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate Eur J Nucl Med Mol Imaging 31 1224 1230 10.1007/s00259-004-1575-0 15197504
21. H Minn A Salonen J Friberg A Roivainen T Viljanen J Långsjö, et al. 2004 Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG J Nucl Med 45 972 979 1:CAS:528:DC%2BD2cXnsFygtr8%3D 15181132
22. L Tessonnier F Sebag FF Palazzo C Colavolpe C De Micco J Mancini, et al. 2008 Does (18)F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35 2018 2025 10.1007/s00259-008-0849-3 1:STN:280:DC%2BD1cnkvVeqtw%3D%3D 18566816
23. F Tenenbaum L Groussin H Foehrenbach F Tissier H Gouya J Bertherat, et al. 2004 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients Eur J Endocrinol 150 789 792 10.1530/eje.0.1500789 1:CAS:528:DC%2BD2cXlvVKitb8%3D 15191348
24. GW Boland MJ Lee GS Gazelle EF Halpern MM McNicholas PR Mueller 1998 Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature AJR Am J Roentgenol 171 201 204 1:STN:280:DyaK1czhtFWhsQ%3D%3D 9648789
25. MD Gross B Shapiro JA Bouffard GM Glazer IR Francis GP Wilton, et al. 1988 Distinguishing benign from malignant euadrenal masses Ann Intern Med 109 613 618 1:STN:280:DyaL1czjvFWhtQ%3D%3D 3421574
26. LM Weiss LJ Medeiros AL Vickery Jr 1989 Pathologic features of prognostic significance in adrenocortical carcinoma Am J Surg Pathol 13 202 206 10.1097/00000478-198903000-00004 1:STN:280:DyaL1M7kvVGntg%3D%3D 2919718
27. LD Thompson 2002 Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases Am J Surg Pathol 26 551 566 10.1097/00000478-200205000-00002 11979086
28. EM Caoili M Korobkin IR Francis RH Cohan JF Platt NR Dunnick, et al. 2002 Adrenal masses: characterization with combined unenhanced and delayed enhanced CT Radiology 222 629 633 10.1148/radiol.2223010766 11867777
29. SR Martínez de Llano RC Delgado-Bolton A Jiménez-Vicioso MJ Pérez-Castejón JL Carreras Delgado E Ramos, et al. 2007 Meta-analysis of the diagnostic performance of 18F-FDG PET in renal cell carcinoma Rev Esp Med Nucl 26 19 29 10.1157/13097378 17286945 Spanish
30. S Leboulleux C Dromain G Bonniaud A Aupérin B Caillou J Lumbroso, et al. 2006 Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography J Clin Endocrinol Metab 91 920 925 10.1210/jc.2005-1540 1:CAS:528:DC%2BD28Xis1CmtL4%3D 16368753
31. S Aubert A Wacrenier X Leroy P Devos B Camaille C Proye, et al. 2002 Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors Am J Surg Pathol 26 1612 1619 10.1097/00000478-200212000- 00009 12459628